Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
03/1999
03/11/1999WO1999011290A1 Use of propyl gallate to increase bioavailability of orally administered pharmaceutical compounds
03/11/1999WO1999011286A1 Vaginal suppository vaccine for urogenital infections
03/11/1999WO1999011275A2 Use of immunostimulatory oligonucleotides for preventing or reducing antigen-stimulated, granulocyte-mediated inflammation
03/11/1999WO1999011263A1 Combination therapy comprising amlodipine and a statin compound
03/11/1999WO1999011259A1 Therapeutic combinations comprising amlodipin and atorvastatin
03/11/1999WO1999011257A1 Improved compositions and methods for the control of smoking
03/11/1999WO1999011245A1 A pharmaceutical composition having two coating layers
03/11/1999WO1999011240A1 Carotenoid microemulsions
03/11/1999WO1999011208A1 Method and composition for transdermal administration of pharmacologic agents
03/11/1999WO1998056360A3 Film-coated tablet for improved upper gastrointestinal tract safety
03/11/1999DE19738903A1 Therapeutic containing mineral, plant material and animal material
03/11/1999DE19738865A1 Use of oligoglycoside fatty acid esters as emulsifiers
03/11/1999CA2302805A1 Use of immunostimulatory oligonucleotides for preventing or reducing antigen-stimulated, granulocyte-mediated inflammation
03/11/1999CA2302505A1 Vaginal suppository vaccine for urogenital infections
03/11/1999CA2302248A1 Improved compositions and methods for the control of smoking
03/11/1999CA2301157A1 Conjugates that contain the homeodomain of antennapedia
03/11/1999CA2294133A1 Poly(adp-ribose) polymerase ("parp") inhibitors, methods and pharmaceutical compositions for treating neural or cardiovascular tissue damage
03/10/1999EP0900804A2 Analogs for specific oligosaccharide-protein interactions and uses therefor
03/10/1999EP0900559A1 Use of a dispersion based on lipid vesicles as an anti-inflammatory composition
03/10/1999EP0900379A1 RECEPTOR FOR UNDERIVATIZED, AQUEOUS SOLUBLE $g(b)(1-3)-GLUCAN
03/10/1999EP0900088A2 Inclusion complexes of aryl-heterocyclic salts
03/10/1999EP0773951B1 Dinucleoside-5',5'-pyrophosphates
03/10/1999EP0735898B1 Vaccines
03/10/1999EP0714386B1 Water-soluble nimesulide salt, and uses thereof for the treatment of inflammations
03/10/1999EP0505357B1 Method for antibody targeting of diagnostic or therapeutic agents
03/10/1999EP0153926B2 Microdroplets of water-insoluble drugs
03/10/1999CN1210558A Recombinant phages
03/10/1999CN1210466A Colonic delivery of nicotine to treat inflammatory bowel disease
03/10/1999CN1210463A Transparent aqueous solution of diclofenac sodium and medicinal compositions with the use of the same
03/10/1999CN1210462A External preparation containing tranilast and process for producing the same
03/10/1999CN1042394C Pharmaceutical composition containing felbinac
03/09/1999USRE36138 Percutaneous absorption promoter, a tape plaster and a method of promoting percutaneous absorption
03/09/1999US5880287 Polyoxyhydrocarbyl related products and methods for fluorescence assays
03/09/1999US5880270 Aminooxy-containing linker compounds for formation of stably-linked conjugates and methods related thereto
03/09/1999US5880255 Process for fractionating polyethylene glycol (PEG)-protein adducts and an adduct of PEG and granulocyte-macrophage colony stimulating factor
03/09/1999US5880252 Film forming agents and conditioners in hair cosmetic formulations; water or alcohol soluble, low viscosity
03/09/1999US5880163 Oil composition of dihydropolyprenols
03/09/1999US5880133 Mixture containing n-methylpyrrolidone and an acid excipient
03/09/1999US5880131 Polyoxyalkylene derivatives
03/09/1999US5880123 Hemolysis prevention by non-ionic surfactants
03/09/1999US5880106 Containing water insoluble antacid buffering composition combined with dihydroxyaluminum alkali metal carbonate or calcium carbonate, optional excipients; improved bioavailability, reduced side effects
03/09/1999US5879917 Designed to kill selected cells present in hetergenous cell population; cause selective killing of transformed cells, viral-infected cells, etc.
03/09/1999US5879910 Hepatocyte growth factor protease domain variants
03/09/1999US5879877 Separating motile sperm
03/09/1999US5879718 Composition for topical use in the form of a surfactant-free oil-in-water emulsion containing a crosslinked and neutralized poly (2-acrylamido-2-methylpropanesulphonic acid) polymer
03/09/1999US5879717 Wound healing compositions containing iodine and sucrose
03/09/1999US5879711 Stable antiandrogenic gel composition
03/09/1999US5879710 Comprising melatonin and melatonin derivatives, acrylic acid polymeric resin, magnesium stearate, lactose diluent, polyvinylpyrrolidinone and cellulose derivatives
03/09/1999US5879708 Stabilized pharmaceutical composition
03/09/1999US5879707 Comprising a release matrix made of substitued amylose and a powder of a pharmaceutical drug
03/09/1999US5879706 Valaciclovir tablets containing colloidal silicon dioxide
03/09/1999US5879702 Analgesic anti-inflammatory adhesive preparations
03/09/1999US5879701 Transdermal delivery of basic drugs using nonpolar adhesive systems and acidic solubilizing agents
03/09/1999US5879692 Tocopheryl ascorbyl phosphate-cyclodextrin clathrate and a topical dermal composition containing said clathrate
03/09/1999US5879688 Treatment of skin disorders, wrinkling, aging
03/09/1999US5879679 Antigen-based heteropolymers and method for treating autoimmune diseases using the same
03/09/1999US5879656 Radioactive therapeutic agent, receptor binding moiety
03/09/1999CA2059403C Use of carrageenans in topical ophthalmic compositions
03/08/1999CA2242476A1 Novel compositions containing cyclosporin
03/05/1999CA2245754A1 Agent for oral intake, its production and use
03/04/1999WO1999010485A1 Methods using phage display for selecting internalizing ligands for gene delivery
03/04/1999WO1999010362A1 Branched dendrimeric structures
03/04/1999WO1999010014A2 Receptor-mediated gene delivery using bacteriophage vectors
03/04/1999WO1999010011A1 Dried biologically or therapeutically active preparations
03/04/1999WO1999010008A1 Compositions comprising the adjuvant qs-21 and polysorbate or cyclodextrin as excipient
03/04/1999WO1999009997A1 Edta and other chelators with or without antifungal antimicrobial agents for the prevention and treatment of fungal infections
03/04/1999WO1999009990A1 Pharmaceutical suspension comprising nevirapine hemihydrate
03/04/1999WO1999009988A1 New pharmaceutical compositions of meloxicam with improved solubility and bioavailability
03/04/1999WO1999009962A1 In situ formation of polymeric material
03/04/1999WO1999009959A1 Rapidly disintegrating methylcellulose tablets
03/04/1999WO1999009958A1 Rapidly disintegrating methylcellulose tablets
03/04/1999WO1999009957A1 Pharmaceutical composition for combination of piperidinoalkanol-decongestant
03/04/1999WO1999009955A2 Lipid-containing compositions and uses thereof
03/04/1999WO1999009954A1 Non-steroidal antiinflammatory drug formulations for topical application to the skin
03/04/1999WO1998055147A3 Reversible geling co-polymer and method of making
03/04/1999DE19737454A1 New medicament-carrier-conjugate
03/04/1999CA2654522A1 Compositions comprising the adjuvant qs-21 and polysorbate or cyclodextrin as exipient
03/04/1999CA2302293A1 Receptor-mediated gene delivery using bacteriophage vectors
03/04/1999CA2302292A1 Methods using phage display for selecting internalizing ligands for gene delivery
03/04/1999CA2301514A1 Dried biologically or therapeutically active preparations
03/04/1999CA2301304A1 New pharmaceutical compositions of meloxicam with improved solubility and bioavailability
03/03/1999EP0898968A1 Antitumor agent comprising a complex of an oxidoreductase and a polymer and a substrate of the enzyme
03/03/1999EP0898962A1 Transdermal patches and methods for inactivating skin proteases
03/03/1999EP0898961A1 Pharmaceutical composition to improve the therapy of acute, postoperative or chronic pain
03/03/1999EP0898477A1 Topical administration of antimicrobial agents for the treatment of systemic bacterial diseases
03/03/1999EP0820462B1 Hydrolysis and photocleavage of nucleic acid using a metal complex
03/03/1999EP0537276B1 Cancer-associated scm-recognition factor, preparation and method of use
03/03/1999CN1209752A Use of oligosacharides for neutralising E. COLI toxins
03/03/1999CN1209751A Improved concentrated injection and infusion solutions for intravenous administration
03/03/1999CN1209741A Preparations of non-steroidal analgesics
03/03/1999CN1209740A Anti-fungus composition with improved biological utilization ratio
03/03/1999CN1209738A Skin-care composition
03/03/1999CN1209548A Method for preparing carbide resin DNA immunity adsorbent
03/03/1999CN1209315A Improvement of auxiliary material containing chlorohaxanpyridine acetate
03/03/1999CN1042299C Preparation method for improved oral preparation of dideoxy purine nucleosides
03/02/1999US5877302 Compacted nucleic acids and their delivery to cells
03/02/1999US5877296 Reacting disulfide analogs of calicheamicin family with a carrier such as protein, peptide, mono and polyclonal antibodies, their antigen-recognizing fragments and chemically or genetically engineered counterparts
03/02/1999US5877289 Tissue factor compositions and ligands for the specific coagulation of vasculature
03/02/1999US5877263 Process for preparing polymer coatings grafted with polyethylene oxide chains containing covalently bonded bio-active agents
03/02/1999US5877247 Stable magnesium hydroxide slurries
1 ... 1435 1436 1437 1438 1439 1440 1441 1442 1443 1444 1445 1446 1447 1448 1449 1450 1451 1452 1453 1454 1455 ... 1712